LSA
AXSM icon

Leonteq Securities AG’s Axsome Therapeutics AXSM Stock Holding History

Leonteq Securities AG’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$640K Sell
2,616
-28
-1% -$6.07K 0.02% 348
2026
Q1 		$447K Sell
2,644
-575
-18% -$99.3K 0.02% 430
2025
Q4 		$588K Sell
3,219
-518
-14% -$72.3K 0.02% 427
2025
Q3 		$454K Sell
3,737
-48
-1% -$5.41K 0.01% 422
2025
Q2 		$395K Buy
3,785
+250
+7% +$26.5K 0.02% 428
2025
Q1 		$412K Sell
3,535
-3
-0.1% -$342 0.02% 406
2024
Q4 		$299K Hold
3,538
– – 0.02% 459
2024
Q3 		$318K Sell
3,538
-1,185
-25% -$103K 0.02% 395
2024
Q2 		$380K Buy
4,723
+908
+24% +$67.2K 0.03% 360
2024
Q1 		$304K Buy
3,815
+1,465
+62% +$123K 0.02% 408
2023
Q4 		$187K Buy
2,350
+300
+15% +$20.1K 0.01% 512
2023
Q3 		$143K Hold
2,050
– – 0.01% 592
2023
Q2 		$147K Buy
2,050
+1,050
+105% +$77.5K 0.01% 598
2023
Q1 		$61.7K Buy
1,000
+900
+900% +$59.1K ﹤0.01% 752
2022
Q4 		$7.71K Sell
100
-3,100
-97% -$185K ﹤0.01% 1095
2022
Q3 		$143K Buy
3,200
+1,200
+60% +$60K 0.01% 585
2022
Q2 		$76.6K Buy
2,000
+900
+82% +$28.5K ﹤0.01% 735
2022
Q1 		$45.5K Buy
+1,100
New +$34.1K ﹤0.01% 880

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Leonteq Securities AG's AXSM Position: Q2 2026 in Review

Leonteq Securities AG reduced its Axsome Therapeutics (AXSM) stake by 1.1% in Q2 2026, selling an estimated $6.07K and leaving 2,616 shares worth $640K. The position accounts for 0.02% of the portfolio, ranked #348.

Leonteq Securities AG first reported a position in AXSM in Q1 2022 and has held it in 18 quarters since. 502 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Leonteq Securities AG held 2,616 shares of Axsome Therapeutics worth $640K as of Q2 2026.
  • Leonteq Securities AG sold 28 Axsome Therapeutics shares in Q2 2026, an estimated $6.07K.
  • Axsome Therapeutics made up 0.02% of Leonteq Securities AG's portfolio in Q2 2026, its #348 holding.
  • Leonteq Securities AG first reported a position in Axsome Therapeutics in Q1 2022 and has held it in 18 quarters since.
  • 502 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.